Deletion at 6q24.2–26 predicts longer survival of high‐grade serous epithelial ovarian cancer patients

Standard treatments for advanced high‐grade serous ovarian carcinomas (HGSOCs) show significant side‐effects and provide only short‐term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin‐embedd...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamieniak, Marta M., Rico, Daniel, Milne, Roger L., Muñoz-Repeto, Ivan, Ibáñez, Kristina, Grillo, Miguel A., Domingo, Samuel, Borrego, Salud, Cazorla, Alicia, García-Bueno, José M., Hernando, Susana, García-Donas, Jesús, Hernández-Agudo, Elena, y Cajal, Teresa Ramón, Robles-Díaz, Luis, Márquez-Rodas, Ivan, Cusidó, Maite, Sáez, Raquel, Lacambra-Calvet, Carmen, Osorio, Ana, Urioste, Miguel, Cigudosa, Juan C., Paz-Ares, Luis, Palacios, José, Benítez, Javier, García, María J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528660/
https://www.ncbi.nlm.nih.gov/pubmed/25454820
http://dx.doi.org/10.1016/j.molonc.2014.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528660/
https://www.ncbi.nlm.nih.gov/pubmed/25454820
http://dx.doi.org/10.1016/j.molonc.2014.09.010

Ejemplares similares